Dr Ron Davis and his team at the Stanford Genome Technology Center have received a large research grant from the National Institutes of Health (NIH) that will fund research for 5 years at $500,000 a year and will involve 15 collaborators, 9 of which have never worked in the ME/CFS field before. The research will focus on immunology and T-cell activation in people with ME/CFS.
The ROI grant was awarded from the National Institute of Allergy and Infectious Diseases.
“This is an exciting time for ME/CFS,” said Ron Davis, Director of the Stanford Genome Technology Center at Stanford University and the Open Medicine Foundation’s Scientific Advisory Board Director.
Watch as Ron Davis discusses the grant in the video below, produced by Ashley Haugen: